z-logo
open-access-imgOpen Access
cIAP1 promotes proliferation and migration and prevents apoptosis in gallbladder cancer in vitro
Author(s) -
Wei Su,
Xiaojie Jiang,
MingYuan Chen,
Maotuan Huang,
Nanhong Tang,
Xiaoqian Wang,
Xiujin Li,
Feifei She,
Yanlin Chen
Publication year - 2019
Publication title -
bioscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.938
H-Index - 77
eISSN - 1573-4935
pISSN - 0144-8463
DOI - 10.1042/bsr20182266
Subject(s) - apoptosis , cancer research , biology , cycloheximide , tumor necrosis factor alpha , microbiology and biotechnology , cell growth , programmed cell death , immunology , protein biosynthesis , biochemistry
Gallbladder cancer (GBC) is a demanding fatal disease with no ideal treatment for inoperable patients. Recent reports have determined TNF-α associated lymphatic metastasis in GBC, while its resistance to TNF-α-killing remains largely unexplored. In this assay, we first found cellular inhibitor of apoptosis (cIAP1) overexpressed in GBC tissues and the roles in promoting the proliferation and migration of GBC in vitro as its homology cIAP2 does. Then how GBC cell survives TNF-α toxicity and TNF-α-induced apoptosis first prevail as follows. The reduction in cIAP1 does not give rise to apoptosis even with the stimulation of TNF-α. Importantly, the loss of cIAP1 enhanced TNF-α/cycloheximide-induced apoptosis in higher activation statuses of Caspase-8, Caspase-3 without the induction of Complex Ⅱ. In response to TNF-α, the reduction in cIAP1 caused the suppression in nuclear factor-κB (NF-κB) pathway and inhibition of transcription of cell death regulator cellular FLICE-like Inhibitory Protein (c-FLIP) instead. To conclude, cIAP1 is an oncological protein abundant in GBC tissues, which enhances proliferation and immigration and blocks TNF-α from apoptosis through NF-κB pathway in vitro .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here